Cargando…
Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK
Neurodevelopmental disorders (NDDs) and cancer share proteins, pathways, and mutations. Their clinical symptoms are different. However, individuals with NDDs have higher probabilities of eventually developing cancer. Here, we review the literature and ask how the shared features can lead to differen...
Autores principales: | Nussinov, Ruth, Yavuz, Bengi Ruken, Arici, M Kaan, Demirel, Habibe Cansu, Zhang, Mingzhen, Liu, Yonglan, Tsai, Chung-Jung, Jang, Hyunbum, Tuncbag, Nurcan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133437/ https://www.ncbi.nlm.nih.gov/pubmed/37124926 http://dx.doi.org/10.1007/s12551-023-01054-9 |
Ejemplares similares
-
Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome
por: Yavuz, Bengi Ruken, et al.
Publicado: (2023) -
Mechanism of activation and the rewired network: New drug design concepts
por: Nussinov, Ruth, et al.
Publicado: (2021) -
Pan-cancer clinical impact of latent drivers from double mutations
por: Yavuz, Bengi Ruken, et al.
Publicado: (2023) -
AlphaFold, Artificial
Intelligence (AI), and Allostery
por: Nussinov, Ruth, et al.
Publicado: (2022) -
Higher‐order interactions of Bcr‐Abl can broaden chronic myeloid leukemia (CML) drug repertoire
por: Liu, Yonglan, et al.
Publicado: (2023)